Sign Up Today and Learn More About Aardvark Therapeutics Stock
Invest in or calculate the value of your shares in Aardvark Therapeutics or other pre-IPO companies through EquityZen's platform.
Aardvark Therapeutics Stock
Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders.
About Aardvark Therapeutics Stock
Founded
2017
Headquarters
San Diego, CA, US
Industries
Science and Engineering, Health Care, Biotechnology
Aardvark Therapeutics Press Mentions
Stay in the know about the latest news on Aardvark Therapeutics
Aardvark Therapeutics moves closer to float with Series C venture round
thepharmaletter • Jul 02, 2024
Aardvark Raises $85M Series C
sdbj • Jul 02, 2024
San Diego biotech news: Startup gets funding for drug that tackles overeating
sandiegouniontribune • Jul 02, 2024
Aardvark Therapeutics moves closer to float with Series C venture round
thepharmaletter • Jun 19, 2024
Fierce Biotech Fundraising Tracker 2024
fiercebiotech • Jun 04, 2024
Aardvark Therapeutics Management
Leadership team at Aardvark Therapeutics
Founder & CEO
Tien Lee
Board Member
Victor Tong
Join now and verify your accreditation status to gain access to:
- Aardvark Therapeutics current valuation
- Aardvark Therapeutics stock price
- Available deals in Aardvark Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Aardvark Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Aardvark Therapeutics through EquityZen funds. These investments are made available by existing Aardvark Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Aardvark Therapeutics stock?
Shareholders can sell their Aardvark Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."